West Pharmaceutical Services, Inc. (NYSE:WST), a global company involved in innovative solutions for injectable drug administration, announced on Friday that it has received approval from its board of directors for its second-quarter 2023 dividend.
The company has approved a second quarter dividend of USD0.19 per share.
The dividend will be paid to shareholders of record at 26 April 2023 on 3 May 2023.
AbbVie Inc announces quarterly cash dividend
Qilian International announces special one-time cash dividend
Eli Lilly collaborates with International Agencies (Bangladesh) Ltd
Sanofi reports Q4 sales of Dupixent up 42%
AmeriHealth Caritas Promotes Access to COVID-19 Vaccines for Children Ahead of the Winter Months
Eli Lilly collaborates with EVA Pharma to deliver sustainable supply of affordable insulin to Africa